A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
AGILENT TECHNOLOGIES, INC.
A
$39.5B
Mkt Cap
$138.57
-0.84%
AGILENT TECHNOLOGIES, INC. (A) has a current P/E ratio of 30.3, compared to its historical median P/E of 31.1. The stock is currently considered Fair based on its historical valuation range.
AGILENT TECHNOLOGIES, INC. (A) has a 5-year average return on invested capital (ROIC) of 18.6%. This indicates strong capital allocation and a potential competitive advantage.
AGILENT TECHNOLOGIES, INC. (A) has a market capitalization of $39.1B. It is classified as a large-cap stock.
Yes, AGILENT TECHNOLOGIES, INC. (A) pays a dividend with a trailing twelve-month yield of 0.73%. The company also returns capital through share buybacks, with a buyback yield of 0.99%.
Based on historical P/E analysis, AGILENT TECHNOLOGIES, INC. (A) appears fair. The current P/E of 30.3 is 3% below its historical median of 31.1. The estimated fair value CAGR (P/E method) is 12.8%.
AGILENT TECHNOLOGIES, INC. (A) operates in the Laboratory Analytical Instruments industry, within the Technology sector.
Agilent Technologies is a global leader in life sciences, diagnostics, and applied markets, providing instruments, software, services, and consumables for laboratory workflows across three reportable segments. The Life Sciences and Diagnostics Markets segment comprises specialty contract development and manufacturing services for pharmaceutical customers, along with solutions including reagents, instruments, software, and consumables for clinical and life sciences research at the cellular and molecular level, encompassing liquid chromatography, cell analysis, pathology solutions, genomics, and companion diagnostics. The Agilent CrossLab segment spans the entire laboratory with extensive services and consumables portfolios, software, and laboratory automation solutions designed to improve customer outcomes across end-markets and applications. The Applied Markets segment provides application-focused solutions including instruments and software that enable customers to identify, quantify, and analyze physical and biological properties of substances and products. The company sells primarily through direct sales channels supplemented by distributors, resellers, manufacturers' representatives, and electronic commerce, serving pharmaceutical and biopharmaceutical companies, diagnostics and clinical laboratories, academic and government institutions, and customers in chemicals, advanced materials, food, environmental, and forensics markets across North America, Europe, Asia, and other regions.
【Operational momentum accelerating】 Management expects continued health in key end markets supported by commercial execution, differentiated portfolio offerings, and best-in-class service delivery. The company anticipates sustained pricing realization through its strategic pricing capability and Ignite Operating System, with replacement cycle momentum in liquid chromatography and gas chromatography platforms expected to provide meaningful tailwinds. Operating leverage is expected to improve through the remainder of the fiscal year as volume increases combine with Ignite efficiencies and tariff mitigation efforts, while the company remains disciplined on capital deployment focused on organic growth through innovation and capacity expansion alongside strategically attractive M&A opportunities. Management is deploying artificial intelligence within its own business and expanding automation capabilities, particularly leveraging technical talent and innovation ecosystems to support customer needs in emerging areas including digital transformation and laboratory automation.
| Metric | Target | Period |
|---|---|---|
| Revenue | $7.39 billion–$7.49 billion | FY2026 |
| Core revenue growth | 4.5%–6% | FY2026 |
| Operating margin expansion | 85 basis points | FY2026 |
| Earnings per share | $6.00–$6.10 | FY2026 |
| Q3 FY2026 Revenue | $1.83 billion–$1.85 billion | Q3 FY2026 |
| Q3 FY2026 Core growth | 4.4%–5.9% | Q3 FY2026 |
| Q3 FY2026 EPS | $1.48–$1.50 | Q3 FY2026 |
Revenue (FY2026): “we now expect fiscal year 2026 revenue to be in the range of $7.39 billion-$7.49 billion on a reported basis”
Core revenue growth (FY2026): “This range represents growth of 4.5%-6% on a core or organic constant currency basis”
Operating margin expansion (FY2026): “we are also raising our full year operating margin expansion target to 85 basis points at the midpoint of our revenue guidance”
Earnings per share (FY2026): “Fiscal year 2026 earnings per share are now expected to be between $6 and $6.10”
“We expect our reported revenue to be in the range of $1.83 billion-$1.85 billion”
Generated solely from the company's own reports listed below — not from third-party data. Hallucination risk is low. · Sources: 10-K, Q2 FY2026 Earnings Call, Q1 FY2026 Earnings Call, Q4 FY2025 Earnings Call, Q3 FY2025 Earnings Call
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 7.2B | 6.9B | 6.5B | 6.8B | 6.8B | 6.3B |
| Net Income | 1.4B | 1.3B | 1.3B | 1.2B | 1.3B | 1.2B |
| EPS | $5.00 | $4.57 | $4.43 | $4.19 | $4.18 | $3.94 |
| Free Cash Flow | 1.1B | 1.2B | 1.4B | 1.5B | 1.0B | 1.3B |
| ROIC | 16.1% | 16.5% | 16.9% | 17.8% | 22.6% | 19.3% |
| Gross Margin | - | 52.4% | 54.3% | 50.7% | 54.4% | 53.9% |
| Debt/Equity | 0.47 | 0.50 | 0.57 | 0.47 | 0.52 | 0.51 |
| Dividends/Share | $1.01 | $0.99 | $0.94 | $0.90 | $0.84 | $0.78 |
| Operating Income | 1.6B | 1.5B | 1.5B | 1.4B | 1.6B | 1.3B |
| Operating Margin | 21.5% | 21.3% | 22.9% | 19.8% | 23.6% | 21.3% |
| ROE | 19.9% | 20.6% | 22.0% | 22.2% | 23.6% | 23.6% |
| Shares Outstanding | 282M | 285M | 291M | 296M | 300M | 307M |
AGILENT TECHNOLOGIES, INC. passes 5 of 9 quality checks, suggesting mixed fundamentals.
AGILENT TECHNOLOGIES, INC. trades at 30.3x trailing earnings, compared to its 15-year median P/E of 31.1x, suggesting it is currently Fair relative to its historical range. On a free-cash-flow basis, the stock trades at 34.1x vs a median of 28.4x. The company's 5-year average ROIC is 18.6% with a gross margin of 53.1%. Total shareholder yield (dividends + buybacks) is 1.7%. At current prices, the estimated annualized return to fair value is +10.2%.
AGILENT TECHNOLOGIES, INC. (A) reported annual revenue of $6.9 billion in its most recent fiscal year, based on SEC EDGAR filings.
AGILENT TECHNOLOGIES, INC. (A) has a net profit margin of 18.8%. This is a healthy margin.
AGILENT TECHNOLOGIES, INC. (A) generated $1.2 billion in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
AGILENT TECHNOLOGIES, INC. (A) has a debt-to-equity ratio of 0.50. This indicates a conservatively financed balance sheet.
AGILENT TECHNOLOGIES, INC. (A) reported earnings per share (EPS) of $4.57 in its most recent fiscal year.
AGILENT TECHNOLOGIES, INC. (A) has a return on equity (ROE) of 20.6%. This indicates the company generates strong returns for shareholders.
AGILENT TECHNOLOGIES, INC. (A) has a 5-year average gross margin of 53.1%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 19 years of financial data for AGILENT TECHNOLOGIES, INC. (A), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
AGILENT TECHNOLOGIES, INC. (A) has a book value per share of $23.64, based on its most recent annual SEC filing.
Based on recent SEC filings and earnings disclosures, Management expects continued health in key end markets supported by commercial execution, differentiated portfolio offerings, and best-in-class service delivery. The company anticipates sustained pricing realization through its strategic pricing capability and Ignite Operating System, with replacement cycle momentum in liquid chromatography and gas chromatography platforms expected to provide meaningful tailwinds. Operating leverage is expected to improve through the remainder of the fiscal year as volume increases combine with Ignite efficiencies and tariff mitigation efforts, while the company remains disciplined on capital deployment focused on organic growth through innovation and capacity expansion alongside strategically attractive M&A opportunities. Management is deploying artificial intelligence within its own business and expanding automation capabilities, particularly leveraging technical talent and innovation ecosystems to support customer needs in emerging areas including digital transformation and laboratory automation.
Based on recent SEC filings and earnings calls, AGILENT TECHNOLOGIES, INC. (A) has provided the following forward guidance: Revenue: $7.39 billion–$7.49 billion (FY2026); Core revenue growth: 4.5%–6% (FY2026); Operating margin expansion: 85 basis points (FY2026); Earnings per share: $6.00–$6.10 (FY2026); Q3 FY2026 Revenue: $1.83 billion–$1.85 billion (Q3 FY2026), plus 2 additional metrics.
Q3 FY2026 Core growth (Q3 FY2026): “This represents growth of roughly 4.4%-5.9% on a core or organic constant currency basis”
Q3 FY2026 EPS (Q3 FY2026): “EPS guidance for the quarter is $1.48-$1.50”